Eli Lilly Stock News & Updates
[WKN: 858560 | Symbol: LLY]
Eli Lilly (LLY) – The pharmaceutical giant ignites new growth surge with weight-loss medications and significantly raises annual forecast!
Eli Lilly delivers a quarter to marvel at: Revenue +56% to $19.8 billion, EPS at $8.55 far exceeds expectations....
Wall Street and DAX on standby before Fed meeting – Oil prices rise due to ongoing Middle East blockade – Alphabet secures exclusive AI deal with Pentagon – Meta plans giant power supply from space – Eli Lilly revitalizes lucrative weight loss market with new pill – Init Innovation shines with million-dollar contract from Australia
Disappointing user numbers at AI pioneer OpenAI weigh on Nasdaq and burden US indices ahead of Fed...
Trump Reviews Iran’s Offer to Open Hormuz - Bank of Japan Warns of Inflation Surge Due to Iran Conflict - Google Opens Its AI for Secret Pentagon Operations - OpenAI Misses Growth Targets - Shell Accelerates Gas Business with ARC Acquisition - Eli Lilly Cementing its Pharmaceutical Dominance
The US stock market presented itself on Monday, April 27, 2026, in a tense, almost electrifying state....
Multiple Billion-Dollar Deals and Medical Revolution! Eli Lilly Takes the Next Growth Stage with Foundayo!
The US pharmaceutical giant Eli Lilly (LLY) is once again making significant moves in the acquisition...
Eli Lilly: Strong Growth, Strategically Smart and Attractive After Setbacks!
The stock of Eli Lilly (NYSE: LLY) remains, in my view, a high-quality growth asset with an attractive...
Eli Lilly: 2 Billion USD for the Future of Cancer Medicine!
Eli Lilly (NYSE: LLY) is on the verge of acquiring Kelonia Therapeutics for over 2 billion USD. A remarkable...
Diabetes Boom: These Stocks Will Benefit from the $190 Billion Market!
The global market for obesity and diabetes therapies is undergoing a structural reassessment: Investment...
Eli Lilly: Foundayo is Cementing Market Leadership in the Obesity Sector
The market for obesity treatments is currently experiencing a fundamental shift, and Eli Lilly is positioning...
US Stock Markets Continue on Recovery Path – Oil Prices Rise Towards the $100 Mark Again – US Inflation Remains Persistent – Amazon Achieves Strongest Daily Gain in 5 Months – CoreWeave Secures $21 Billion Deal With Meta – Software and Cybersecurity - Stocks Continue to Plummet – Blackberry Surprises With Strong Figures – Eli Lilly Launches Weight Loss Pill Foundayo – SpaceX Reports Massive Losses of $5 Billion
On Thursday, April 9, 2026, Wall Street displayed a clear upward trend, continuing the dynamic recovery...
Trump's Iran Threats Lead to Nervous Reactions on the Markets – Oil Prices Markedly Above $100 – Amazon Negotiates Acquisition of Globalstar – Eli Lilly Competes With New Weight Loss Pill – Tesla Misses Expectations – Biogen Grows Through Billion-Dollar Acquisition of Apellis Pharmaceuticals
Hope for a quick peace in the Middle East vanishes, leading to nervous reactions on US markets ...
The Approval of Eli Lilly’s Obesity Pill Opens a new Front in the Weight-Loss war
Eli Lilly's pill will compete in the booming, billion-dollar market for obesity medications against a...